$0.762
-0.020 (-2.64%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RNTX Prediction & Forecast by Similar Chart Analysis
Alphio's RNTX stock price prediction model matches the current Rein Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.77 (+1.35%). The 1-week path is $0.77 (+0.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Rein Therapeutics Inc Stock?
Rein Therapeutics, Inc. is currently not a strong buy due to its recent performance and financial metrics. The stock closed at $0.76, down 39.03% year-to-date and 43.55% over the past year, indicating significant volatility and investor concern. The RSI is at 33.698, suggesting the stock is oversold, but the negative trend in net income, which showed a loss of $63.75 million in Q2 2026, raises caution. The main risk is the company's high debt-to-equity ratio of 42.47% in Q1 2026, which could impact financial stability.
RNTX stock price ended at $0.76 on Friday, after losing -2.64%
Rein Therapeutics Inc (RNTX) last closed at $0.7621, losing -2.64%. These facts feed the 1-day and 1-week RNTX price prediction above.
Forecast Drivers
Rein Therapeutics Inc (RNTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RNTX, ranked by similarity.
Seasonality analysis for RNTX
Historically the probability of a positive August return for RNTX is 0.00%. April offers the highest probability of a positive month at 64.06%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RNTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.43 | $1.49 | $1.58 | +95.11% |
| Sep 2026 | $1.43 | $1.71 | $1.82 | +124.99% |
| Oct 2026 | $1.60 | $1.65 | $1.90 | +116.05% |
| Nov 2026 | $1.15 | $1.27 | $1.41 | +66.34% |
| Dec 2026 | $1.16 | $1.49 | $1.71 | +95.32% |
In 2026, Rein Therapeutics Inc (RNTX) is projected to range from $1.15 to $1.90.
Rein Therapeutics Inc 2026 monthly forecast
In Aug 2026, Rein Therapeutics Inc is projected to average $1.49, with a low of $1.43 and high of $1.58.
In Sep 2026, Rein Therapeutics Inc is projected to average $1.71, with a low of $1.43 and high of $1.82.
In Oct 2026, Rein Therapeutics Inc is projected to average $1.65, with a low of $1.60 and high of $1.90.
In Nov 2026, Rein Therapeutics Inc is projected to average $1.27, with a low of $1.15 and high of $1.41.
In Dec 2026, Rein Therapeutics Inc is projected to average $1.49, with a low of $1.16 and high of $1.71.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.